Structural features of thyroglobulin linked to protein trafficking
Protein Science · 2023-11 · 32 (11)
DOI: 10.1002/pro.4784 ↗At a glance
Journal article in Protein Science, published online on 2023-10-16. Written by Cintia E Citterio and 5 co-authors. Institution: Division of Metabolism, Endocrinology & Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA. Major MEDLINE topics: Thyroglobulin, Protein Folding. Cited 7 times so far (Crossref); 32 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (original language)
Thyroglobulin must pass endoplasmic reticulum (ER) quality control to become secreted for thyroid hormone synthesis. Defective thyroglobulin, blocked in trafficking, can cause hypothyroidism. Thyroglobulin is a large protein (~2750 residues) spanning regions I–II–III plus a C‐terminal cholinesterase‐like domain. The cholinesterase‐like domain functions as an intramolecular chaperone for regions I–II–III, but the folding pathway leading to successful thyroglobulin trafficking remains largely unknown. Here, informed by the recent three‐dimensional structure of thyroglobulin as determined by cryo‐electron microscopy, we have bioengineered three novel classes of mutants yielding three entirely distinct quality control phenotypes. Specifically, upon expressing recombinant thyroglobulin, we find that first, mutations eliminating a disulfide bond enclosing a 200‐amino acid loop in region I have surprisingly little impact on the ability of thyroglobulin to fold to a secretion‐competent state. Next, we have identified a mutation on the surface of the cholinesterase‐like domain that has no discernible effect on regional folding yet affects contact between distinct regions and thereby triggers impairment in the trafficking of full‐length thyroglobulin. Finally, we have probed a conserved disulfide in the cholinesterase‐like domain that interferes dramatically with local folding, and this defect then impacts on global folding, blocking the entire thyroglobulin in the ER. These data highlight variants with distinct effects on ER quality control, inhibiting domain‐specific folding; folding via regional contact; neither; or both.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Metabolism, Endocrinology & Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Biomedical and Pharmaceutical Sciences, Chapman University, Irvine, California, USA.
- Departments of Anesthesiology, and Physiology and Cellular Biophysics, Irving Institute for Clinical and Translational Research, Columbia University Irving Medical Center, New York, New York, USA.
ORCID profiles: Peter Arvan
Funding
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Cite
APA
Citterio, C. E., Kim, K., Rajesh, B., Pena, K., Clarke, O. B., & Arvan, P. (2023). Structural features of thyroglobulin linked to protein trafficking. Protein Science, 32(11). https://doi.org/10.1002/pro.4784
Vancouver
Citterio CE, Kim K, Rajesh B, Pena K, Clarke OB, Arvan P. Structural features of thyroglobulin linked to protein trafficking. Protein Science. 2023;32(11). doi:10.1002/pro.4784
BibTeX
@article{Citterio2023,
author = {Citterio, Cintia E and Kim, Kookjoo and Rajesh, Bhavana and Pena, Kevin and Clarke, Oliver Biggs and Arvan, Peter},
title = {Structural features of thyroglobulin linked to protein trafficking},
journal = {Protein Science},
year = {2023},
volume = {32},
number = {11},
doi = {10.1002/pro.4784}
}
EUVIMED